NDC Code(s) : 63323-494-41, 63323-494-16
Packager : Fresenius Kabi USA, LLC
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| Valproate Sodium VALPROATE SODIUM INJECTION, SOLUTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
| LABELER - Fresenius Kabi USA, LLC (608775388) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
| Fresenius Kabi USA, LLC | 840771732 | analysis(63323-494), manufacture(63323-494) | |
PRINCIPAL DISPLAY PANEL
PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Valproate Sodium 5 mL SIngle Dose Vial Label
NDC 63323-494-41
Valproate Sodium
Injection, USP
500 mg* per 5 mL
(100 mg per mL)
For intravenous infusion only.
Preservative free.
5 mL Single-dose Vial Rx only

PRINCIPAL DISPLAY PANEL
PACKAGE LABEL - PRINCIPAL DISPLAY PANEL - Valproate Sodium 5 mL Single Dose Vial Tray Label
NDC 63323-494-16
Valproate Sodium
Injection, USP
500 mg* per 5 mL
(100 mg per mL)
For intravenous infusion only.
Preservative free.
10 x
5 mL
Single-dose Vials Rx only








